21 CFR 520.1855

§ 520.1855 Ponazuril.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.1855, § 520.1855 Ponazuril, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87282
Permanent ID: ys:prov:87282@1
SHA-256: b37b7c41701acbcf2ec879af6d7ce15809994fded198d67219b9f3a0f63d7eae

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each gram of paste contains 150 milligrams (mg) ponazuril. (b) Sponsor. See No. 000010 in § 510.600(c) of this chapter. (c) Conditions of use in horses—(1) Amount. Administer orally 15 mg per kilogram (kg) (6.81 mg per pound (lb)) body weight as the first dose, followed by 5 mg/kg (2.27 mg/lb) body weight once daily for a period of 27 additional days. (2) Indications for use. For the treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona. (3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.